Notícias

THC raised its 2026 outlook after Q2 earnings and revenues beat expectations, driven by strong same-facility growth and disciplined expense management.

UnitedHealth Group (UNH) just released its second quarter 2026 results, giving investors fresh insight into how the healthcare giant is performing and what its latest capital returns and earnings figures might mean for the stock. See our latest analysis for UnitedHealth Group. UnitedHealth Group’s latest earnings and ongoing buybacks come as the stock consolidates after a strong run, with a 30-day share price return of 3.68% and a 90-day share price return of 18.55%. The 1-year total...

Artificial intelligence (AI) infrastructure spending is vaulting GE Vernova to new heights.

The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.

HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 9.7% over the past six months, topping the S&P 500 by 1.8 percentage points.

UnitedHealth Group (UNH) just delivered the quarter battered shareholders have been waiting for. The health care company blew past Wall Street's profit prediction, increased its most widely monitored cost index, and boosted its full-year earnings outlook. The results seemed to vindicate investors ...

Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.

UnitedHealth Group (UNH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.

Investors are rightly focused on the company's Medicaid struggles, but the real upside story may be hiding in plain sight across the rest of its business.

UnitedHealth's stock is flying high after it raised guidance, but on its latest earnings call, analysts zeroed in on an underlying margin divergence running right through the business.

You probably own a lot more of this one high-flying health insurer than you realize, tucked away inside your favorite funds.

The Dow gained 500 points on Tuesday, but chip stocks were still running the show. The blue-chip index was up 0.9%, while the Nasdaq was up 1.4%. The S&P 500 was up 0.9%. Only half the Dow stocks were up on the day, but Caterpillar, UnitedHealth, and Goldman Sachs were all up 3% or more.

UnitedHealth (UNH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

The leading health insurer recently posted strong quarterly results that could drive the stock higher.

FAST, GD, UNH, TXRH and DGX are five stocks that combine long records of uninterrupted payouts with stable earnings and solid cash flow.

UnitedHealth’s $5 billion buyback announcement signals that the healthcare giant’s turnaround is gaining momentum, making it a lucrative opportunity.

Does UnitedHealth Group (UNH) have what it takes to be a top stock pick for momentum investors? Let's find out.

The stock is trading near 52-week highs, but under the surface, commercial segment cost trends are creating headwinds.

Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

Truist, Oppenheimer and KeyBanc moved to $500 targets, with Oppenheimer saying UnitedHealth “handily” beat expectations.

UnitedHealth Group (UNH) beat Wall Street's numbers on July 16, 2026, but its chief financial officer spent the earnings call making sure nobody mistook that result for a solved cost problem. The company beat earnings estimates by roughly 30%, and management raised full-year guidance well past ...

UnitedHealth Group stock has delivered a 54.8% return over the past year, yet the broader valuation checks point to a mixed picture rather than a straightforward bargain or clear overvaluation. UnitedHealth Group's 54.8% gain over the last 12 months puts recent buyers in a strong position, but it also raises the bar for what counts as good value from here. On the positive side, recent earnings strength and margin improvements can support the case that the current price still reflects...

Losing nearly one million Medicare Advantage members would normally be enough to send investors running. Not this time. Buried in UnitedHealth Group Inc’s second-quarter earnings report Thursday morning was a striking statistic: the company has lost 965,000 Medicare Advantage members...

The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from now.

The health insurer raised its forecast after a solid quarter, but investors focused on the one business so broken it’s forcing a strategic retreat.

Jim Cramer named five blue-chip stocks the market punished after strong earnings, and he's betting that millions of investors and billions of dollars got it completely wrong.

Check out the companies making headlines this week: